Valls V - Search Results

1

Clinical presentation of HIV infection in patients aged 50 years or older.

Ena J, Valls V, López Aldeguer J, García Gascó MP, Añón S, Navarro V, Sánchez R, Boix V, Portilla J, Roig P, Masiá MM, Maestre Peiró A. Ena J, et al. Among authors: valls v. J Infect. 1998 Nov;37(3):213-6. doi: 10.1016/s0163-4453(98)91828-x. J Infect. 1998. PMID: 9892523

2

Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis.

Ena J, Valls V. Ena J, et al. Among authors: valls v. Clin Infect Dis. 2005 Mar 1;40(5):670-6. doi: 10.1086/427802. Epub 2005 Feb 1. Clin Infect Dis. 2005. PMID: 15714411

3

Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.

Torrús D, Portilla J, Hernández-Aguado I, Boix V, Plazas J, Gimeno A, Torromé M, Llopis C, Valls V, Sánchez-Payá J. Torrús D, et al. Among authors: valls v. Eur J Clin Microbiol Infect Dis. 1999 Sep;18(9):630-5. doi: 10.1007/s100960050363. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10534184

4

Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials.

Ena J, Valls V. Ena J, et al. Among authors: valls v. Clin Exp Med. 2023 Aug;23(4):1189-1196. doi: 10.1007/s10238-022-00876-3. Epub 2022 Sep 1. Clin Exp Med. 2023. PMID: 36048371 Free PMC article.

5

Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy.

Valls V, Ena J. Valls V, et al. Clin Rheumatol. 2015 Jan;34(1):29-34. doi: 10.1007/s10067-014-2495-4. Epub 2014 Jan 25. Clin Rheumatol. 2015. PMID: 24464437 Clinical Trial.

6

Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload.

Valls V, Ena J, Enríquez-De-Salamanca R. Valls V, et al. J Dermatol Sci. 1994 Jun;7(3):169-75. doi: 10.1016/0923-1811(94)90092-2. J Dermatol Sci. 1994. PMID: 7918235 Clinical Trial.

7

Evaluation of the SENIC risk index in a Spanish university hospital.

Valls V, Díez M, Ena J, Gutiérrez A, Gómez-Herruz P, Martín A, Gónzalez-Palacios R, Granell J. Valls V, et al. Infect Control Hosp Epidemiol. 1999 Mar;20(3):196-9. doi: 10.1086/501611. Infect Control Hosp Epidemiol. 1999. PMID: 10100547

8

Adenosine deaminase activity in cerebrospinal fluid: a useful test for meningeal tuberculosis, even in patients with AIDS.

Ena J, Crespo MJ, Valls V, de Salamanca RE. Ena J, et al. Among authors: valls v. J Infect Dis. 1988 Oct;158(4):896. doi: 10.1093/infdis/158.4.896. J Infect Dis. 1988. PMID: 3171234 No abstract available.

9

Significance of adenosine deaminase measurement in sera of patients with HIV-1 infection.

Valls V, Ena J, Roca V, Perez-Oteyza C, Angeles Figueredo M, Enriquez-de-Salamanca R. Valls V, et al. AIDS. 1990 Apr;4(4):365-6. AIDS. 1990. PMID: 2350457 No abstract available.

10

Efficacy and safety of bemiparin compared with enoxaparin: Meta-analysis of randomized controlled trials.

Ena J, Valls V. Ena J, et al. Among authors: valls v. Int J Clin Pharmacol Ther. 2020 Nov;58(11):617-625. doi: 10.5414/CP203750. Int J Clin Pharmacol Ther. 2020. PMID: 32729821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters